Page 290 - Read Online
P. 290

Lai et al.                                                                                                                                                                                          Robotic hepatectomy for HCC

           analysis of minor hepatectomies, when compared with   rate and hospital stay. However, robotic surgery is more
           the conventional laparoscopic approach, the robotic   expensive than conventional laparoscopic approach. It
           group had similar blood loss (mean, 373.4 vs. 347.7   should be emphasized that considering robot-assisted
           mL), morbidity rate (3% vs. 9%), mortality rate (0%   laparoscopic partial hepatectomy requires 4 conditions:
           vs. 0%), and R0 resection rate (90.9% vs. 90.9%).   (1) appropriate selection of patients; (2) follow the
           However, the robotic group had a significantly longer   principle of open liver surgery; (3) specific expertise
           operative time (202.7 vs. 133.4 min). Recently, Lai   and training, in both liver and laparoscopic surgery;
           and Tang [34]  also compared the long-term oncological   and (4) familiarization with the robotic machine and pay
           outcomes of robotic (n = 100) and conventional     precaution of its potential dangers, such as visceral
           laparoscopic partial hepatectomy (n = 35) for HCC.   injury by robotic arm, total loss of tactile feedback.
           Robotic group had a significant higher proportion   For the oncological outcome for robotic resection
           of major hepatectomies (27% vs. 2.9%) and tumors   of HCC, the data are very limited. Oncological data
           located at or across posterosuperior segments (29%   from homogenous series of HCC after robotic partial
           vs. 0%) than conventional laparoscopic group. For the   hepatectomy was needed. Its future implementation
           perioperative outcomes, robotic group had a significant   and clinical value will depend on the advantages that
           longer mean operating time (207.4 vs. 134.2 min).   it can provide over conventional laparoscopy or open
           Both groups had similar blood loss (334.6 vs. 336 mL).   surgery.
           There was no difference in morbidity (14% vs. 20%)
           and mortality rate (0% vs. 0%). Concerning oncological   DECLARATIONS
           outcomes, there was no difference between 2 groups
           in R0 resection rate (96% vs. 91.4%), 5-year overall   Authors’ contributions
           survival (65% vs. 48%), and disease-free survival (42%   Proposed the idea, structure, and content: E.C.H. Lai
           vs. 38%). Recently, Magistri et al. [35]  also reported the   Literature search: E.C.H. Lai, D.T.M. Chung, O.C.Y.
           short-term outcomes of patients who had underwent   Chan
           robotic resections (n = 22) and laparoscopic (n = 24)   First draft: E.C.H. Lai
           resections for HCC. In the robotic group, there were 6   Revision and final proof read: D.T.M. Chung, O.C.Y.
           left lateral sectionectomies, 2 right hepatectomies, and   Chan, C.N. Tang
           14 minor resections, including 9 segmentectomies and
           5 wedge resections. In the laparoscopic group, there   Financial support and sponsorship
           were 14 segmentectomies and 10 wedge resections,   None.
           but no major hepatectomies. Operating time was
           significantly longer in the robotic group (318 vs. 211 min),   Conflicts of interest
           whereas estimated blood loss was comparable        There are no conflicts of interest.
           between the two groups (400 vs. 320 mL), with one
           case needed blood transfusion in each group. In    Patient consent
           the robotic group, Clavien-Dindo classes I and II   Not applicable.
           complication was significantly less frequent than in
           the laparoscopic group (n = 13 vs. n = 22). During   Ethics approval
           analyzing specific complications, pleural effusion was   Not applicable.
           significantly less frequent in the robotic group (n = 2
           vs. n = 10). Regarding major complications, there were   REFERENCES
           no differences of incidence among the two cohorts
           (n = 2 vs. n = 3). In both the groups, one case of R1   1.   Lai  EC, Tang  CN, Yang GP, Li  MK. Multimodality  laparoscopic
           resection was observed. They also found that robotic   liver  resection for hepatic  malignancy--from conventional  total
           surgery allowed the surgeon to safely deal with liver   laparoscopic approach to robot-assisted laparoscopic approach. Int J
           segments that are difficult to resect in laparoscopic   Surg 2011;9:324-8.
           approach, such as segments I-VII-VIII.             2.   Lai  EC, Tang  CN, Li  MK. Conventional  laparoscopic  and  robot-
                                                                 assisted laparoscopic  liver  resection  for benign and malignant
                                                                 pathologies: a cohort study. J Robot Surg 2012;6:295-300.
           CONCLUSION                                         3.   Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I,
                                                                 Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G,
           Although little data regarding robotic liver surgery   Kaneko H, Ker CG,Scatton O, Laurent A, Abdalla EK, Chaudhury P,
                                                                 Dutson E, Gamblin C, D’Angelica M, Nagorney D, Testa G, Labow
           have been reported, it appears to be superior to open   D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC,
           approach, particularly blood loss and hospital stay, and   Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J,
           similar to conventional laparoscopic approach in terms   Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil
           of operative time, blood loss, morbidity rate, mortality   R, Belghiti J, Strasberg S, Chari RS; World Consensus Conference on
            282                                                                                                     Hepatoma Research ¦ Volume 3 ¦ November 27, 2017
   285   286   287   288   289   290   291   292   293   294   295